ArticleBreast cancer (Dove Medical Press)2023

Differences in Treatment Outcomes Between Patients with HER2-Low versus HER2-Zero, Hormone Receptor-Positive Advanced-Stage Breast Cancer Treated with Ribociclib.

Baha' Sharaf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.